Genetic Analysis AS (NGM:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 1.280
+0.060 (4.92%)
At close: May 13, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 59.36 million as of May 13, 2025. Its market cap has increased by 142.36% in one year.
Market Cap
59.36M
Enterprise Value
56.08M
Revenue
20.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.28
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 59.36M, a decrease of -74.79%. That is a compound annual growth rate of -31.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 56.62M | 131.48% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 102.97B |
| Sectra AB | 59.23B |
| Getinge AB | 50.70B |
| Camurus AB | 39.14B |
| Medicover AB | 36.18B |
| AddLife AB | 22.95B |
| Vitrolife AB | 21.42B |
| Vimian Group AB | 20.64B |